Deshpande, N., Sha, W., Owuor, S., Call, J., Langefeld, C., Morris, S., Nguyen, G., Druhan, L., Ai, J., Knight, T. G., Ragon, B. K., Chojecki, A. L., Shah, N. A., Sanikommu, S., Pang, Y., Grunwald, M. R., Patel, J. N. (2026). Pharmacogenetic (PGx) markers of cardiovascular side effects (CVSEs) in allogeneic hematopoietic cell transplant (HCT) patients receiving post-transplant cyclophosphamide (PTCy).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6559